A single-cell transcriptome map of sheep fat tail and its construction method and application
Through phased concurrent estrus and artificial insemination treatment, combined with high-quality single-cell suspension preparation and single-cell sequencing technology, a sheep fat tail single-cell transcriptome map was constructed, solving the difficulties in data analysis and gene expression specificity in the existing technology. The evaluation issues have achieved in-depth analysis of sheep fat tail tissue and improved production efficiency.
Patent Information
- Application Number
- CN202311740377.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-18
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2043-12-18
AI Technical Summary
Existing single-cell transcriptome technologies are difficult to effectively analyze the genetic regulatory mechanisms of slut fat tail adipogenesis, especially under the large volume and complex nature of adipocytes, which leads to difficulty in data analysis and lack of effective methods for specific evaluation of gene expression.
Using phased estrus and artificial insemination treatment, tail tissue samples from different embryo development stages were accurately collected, and high-quality single-cell suspension was prepared through the combined digestion of collagenase, DNAse and trypsin, combined with 10x Genomics' Chromium Next GEM technology Single-cell sequencing, data alignment and pre-processing were performed using Cell Ranger and Seurat software, cell annotation and quality control were performed based on known marker genes, and transcriptome maps of smear-tailed single-cells were constructed, and genes were evaluated by GO functional enrichment analysis. Expression specificity.
In-depth analysis of sheep fat tail tissue was achieved, high-quality single-cell transcriptome map was constructed, gene expression specific evaluation was enriched, theoretical basis for improving sheep tail type and improving productivity, and reduced data analysis batch effect and parent effect.
Smart Images

Figure CN117925847B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, and in particular to a sheep fat tail single-cell transcriptome map and a construction method and application thereof. Background Art
[0002] Fat tail has become one of the target traits that urgently need to be improved in modern mutton production. As one of the main meat foods, mutton is tender, has a unique flavor, and is high in protein, and is deeply favored by consumers. According to statistics, most sheep breeds are fat-tailed sheep and fat-hipped sheep. The weight of tail fat (tail fat) in fat-tailed sheep can account for 10% to 20% of the carcass weight. With the transition of mutton farming to large-scale intensive house feeding, people's living standards have improved, and their eating habits and dietary structure have changed. In particular, the preference for fat has gradually decreased, and a large amount of tail fat deposition has caused feed waste, resulting in high feed-to-meat ratio and reduced profits. Problems, restricting the high-quality development of the sheep industry, in-depth analysis of the tail fat deposition mechanism can provide an important theoretical basis for improving sheep tail shape, improving production efficiency, and improving carcass quality.
[0003] The fat tail trait is affected by multiple factors such as genetics, nutrition, and feeding management. Many existing studies have shown that it is difficult to analyze its genetic regulatory mechanism using only traditional genomics or transcriptomics techniques. Since single-cell sequencing technology was first applied to basic research, after more than ten years of development, the technology has become more mature and widely used in developmental biology and tissue heterogeneity research, providing a new opportunity for in-depth analysis of tail fat deposition. However, the application of this technology in the field of adipogenesis-related research is very challenging. First, the diameter of mature adipocytes can reach about 100 μm, while high-throughput single-cell separation technology (microfluidics, microdroplets) can only separate cells with a diameter of less than 40 μm; secondly, during the single-cell separation process, due to their large size, adipocytes are very easy to rupture, and mature adipocytes are mostly distributed in the upper layer of the suspension, which has a strong preference during suspension processing and sequencing, making subsequent data analysis difficult.
[0004] Cell annotation is a key step in single-cell transcriptome data analysis. Currently, cell annotation is mainly achieved through two strategies: one method is manual annotation based on the expression of known marker genes; the other method is automatic annotation of cells using software such as scAnnotate and SingleR. Both methods rely on known marker gene information. However, there are currently few known and effectively usable marker genes for different cell types, and there is a lack of gene expression specificity information. Therefore, it is necessary to further study methods for evaluating gene expression specificity. Summary of the invention
[0005] One of the purposes of the present invention is to provide a method and application for constructing a single-cell transcriptome map of sheep fat tail and evaluating gene expression specificity based on single-cell transcriptome sequencing technology.
[0006] In order to achieve this object, the technical solution of the present invention is as follows:
[0007] A method for constructing a single-cell transcriptome map of sheep fat tail, comprising:
[0008] (1) Tail tissue samples of sheep at different embryonic development stages before and after tail fat deposition occurred were collected and prepared into single cell suspensions;
[0009] (2) capturing a single cell in the single cell suspension, performing cell lysis, cDNA synthesis, cDNA library quality inspection, fragmentation and end repair, constructing a sequencing library, and performing sequencing on a machine to obtain raw test data;
[0010] (3) comparing the original test data with the reference genome to obtain the original comparison data and the gene expression matrix in each cell;
[0011] (4) Performing cell quality control based on the number of mRNAs captured by each cell and the proportion of mitochondrial genes; removing genes expressed in less than 10 cells; performing dual-cell prediction and filtering to obtain samples of each period after quality control, merging the samples of each period after quality control, and obtaining a gene-cell expression matrix (clean count matrix) after quality control for downstream analysis;
[0012] (5) performing data preprocessing on the gene-cell expression matrix after quality control;
[0013] (6) Cell annotation was performed based on known marker genes of different cell types to construct a single-cell transcriptome map of sheep fat tail.
[0014] In step (1) of the method of the present invention, the estrus time and the breeding time are adjusted by synchronizing estrus and artificial insemination in stages, so as to ensure that tail tissue samples of sheep at different embryonic development stages before and after tail fat deposition occur are collected simultaneously; and the same male parent is used for breeding of each female parent;
[0015] Preferably, the estrus synchronization and artificial insemination treatment method comprises:
[0016] The progesterone sponge plug was implanted in the vagina and removed after 11 days; 1 ml of 0.1 mg / ml cloprostenol injection was injected intramuscularly; estrus identification was performed with a test ram 2 days later; semen of the breeding ram was collected, and the semen was diluted with vitamin B12 injection and the sperm motility was examined under a microscope. The volume ratio of the vitamin B12 injection to semen was 3:1. After the sperm motility was greater than 50% under the microscope, artificial insemination was performed on the estrus ewe, and insemination was performed 3 times in total, once every 12 hours; after 30 days of mating, estrus identification was performed using a B-ultrasound instrument;
[0017] And / or, the different embryonic development stages refer to 50, 55, 60, 63, 66, 69, 72, 75 and 80 days of gestation.
[0018] And / or, in step (1), when preparing a single cell suspension, collagenase IV, DNase and trypsin are used to digest the tissue, and erythrocytes are lysed using erythrocyte lysis solution to obtain a single cell suspension; preferably, the working concentration of collagenase IV is 2.5 mg / mL, the working concentration of DNase is 15 μg / mL, and the working concentration of trypsin is 0.25% (w / v).
[0019] The cell concentration in the single cell suspension is 500-2000 / ul, and the total number of cells is >10 6 The cell viability was >86%.
[0020] The present invention uses a method of synchronous estrus and artificial insemination in stages, and collects sheep tail tissue samples at different developmental stages at the same time, effectively eliminating the batch effect in the data analysis process; and selects samples from multiple embryonic development periods to make the constructed map information more comprehensive. In the method of the present invention, all estrus ewes are bred with semen from the same breeding ram, thereby eliminating the paternal effect.
[0021] In step (2) of the method of the present invention, the quality inspection standard of the cDNA library is that the fragment length range is 200-9000 bp, and the main peak is between 1000-2000 bp;
[0022] After constructing the sequencing library, the sequencing library is first quality checked before being sequenced on the machine. The quality inspection standard of the sequencing library is that the peak shape is between 250bp-1500bp, the main peak is between 400-500bp, and there is no adapter contamination;
[0023] And / or, the amount of sequencing data on the machine is 150GB / 5000 cells.
[0024] In step (3) of the method of the present invention, the original comparison data includes: the predicted number of cells in each period, the average number of reads of each cell, the median number of gene UMIs, sequencing saturation, comparison rate, the total number of genes and the median number of cell UMIs.
[0025] In step (4) of the method of the present invention, the method of cell quality control includes: calculating the outliers between the mitochondrial gene ratio of each cell in each sample and the overall mitochondrial gene ratio, screening the minimum mitochondrial gene ratio with adjust p value<0.05 as the threshold of each sample, deleting cells with a mitochondrial gene ratio higher than the threshold in each sample, and deleting cells with a UMI number<300.
[0026] In step (5) of the method of the present invention, the data preprocessing includes: performing data standardization based on the expression levels of all genes in each cell; performing data normalization on multiple genes with the highest expression level variation; performing linear and nonlinear dimensionality reduction on the data; and performing cluster analysis on all cells to divide the cell populations.
[0027] In step (6) of the method of the present invention, the known marker genes include: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myogenic progenitor cell, muscle satellite cell, myoblast and muscle cell marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
[0028] The problems encountered during the research of the present invention are: 1. It is difficult to determine the appropriate sampling time point; 2. How to accurately obtain samples at different time points; 3. How to reduce the batch effect in the data analysis process; 4. The tail tissue is complex, how to effectively digest it, etc.
[0029] The dynamic development process of sheep embryos, the key time nodes of development of various tissue parts and the optimal sampling time have not been reported before the present invention, especially the embryonic development pattern of sheep fat tail tissue involved in the present invention has rarely been paid attention to, and the development process is unknown. For this reason, at the beginning of the present invention, tail tissue samples at four time nodes, namely 60, 70, 80 days of pregnancy and adulthood, were collected by conventional breeding means. Based on a large number of tissue morphological analyses and general transcriptomics studies, it was predicted that 70 days of embryonic age is the key period of tail tissue development. At the same time, the study found that a large amount of fat is deposited in the tail tissue in the adult stage, and the cell diameter is too large to apply single-cell sequencing technology. The diameter range of 80-day-old fat cells is 14-20 μm, which fully meets the technical requirements.
[0030] The following difficulties were encountered during this process: (1) The developmental time intervals of 60, 70, and 80 days of gestation were too long, and the morphology and transcript levels of the lipid tail tissue changed dramatically, making it impossible to fully explore scientific issues such as the key genes, pathways, and molecular mechanisms that regulate lipid tail development; (2) Conventional breeding methods lead to complicated sample preparation, and there are also empty-bowel situations; (3) Batch effects caused by processes such as multiple tissue digestion and library preparation will lead to excessive background noise in downstream analysis, making it impossible to scientifically and objectively construct a single-cell transcriptome map.
[0031] To solve the above problems, the present invention (1) re-evaluates the sampling time points and ultimately selects 50, 55, 60, 63, 66, 69, 72, 75 and 80 days of gestation, with a time interval of 5 days between early and late development, and a time interval of 3 days between important developmental stages; (2) adopts a phased synchronous estrus and artificial insemination method to explore a stable process of progesterone treatment, estrus stimulation, estrus identification, artificial insemination and pregnancy detection, thereby avoiding the influence of empty pregnancy, batch effect and paternal effect on downstream analysis; (3) skin, bone and fat tissues can be digested with collagenase I to prepare cell suspension, but preliminary experimental results show that the use of collagenase I alone leads to problems such as long tissue digestion time, low digestion efficiency and poor cell activity. The present invention further optimizes the tissue digestion method and uses collagenase IV, DNase and trypsin in combination to successfully prepare high-quality single cell suspension.
[0032] The present invention also provides a single-cell transcriptome map of sheep fat tail, which is constructed and obtained by the above method.
[0033] In detail, the present invention accurately collects tail tissue samples at different embryonic development stages before and after tail fat deposition occurs to explore the developmental pattern of the fat tail; prepares high-quality single-cell suspension by enzymatic digestion; captures cells, constructs libraries and sequences them; compares the original sequencing data to the reference genome to obtain comparison statistics and a cell-gene expression matrix (barcode-features matrix); performs cell quality control to filter dead cells, low-quality cells and double cells; preprocesses the cell-gene expression matrix, including matrix standardization, identification of highly variable genes, data dimensionality reduction and division of cell groups; performs cell annotation based on known marker genes of different cell types to explore tissue heterogeneity; performs gene differential expression analysis to identify highly expressed genes in each cell group; performs GO function enrichment analysis of highly expressed genes to further verify the accuracy of the annotation results; and performs specificity evaluation based on the highly expressed gene set.
[0034] Specifically, 1. Accurately collect tail tissue samples at different embryonic development stages before and after tail fat deposition to explore the developmental pattern of the fat tail
[0035] Sheep tail fat deposition is a dynamic development process from scratch, so the present invention collects tail tissue samples of Tan sheep embryos at different developmental stages. In order to reduce the batch effect that may occur in sampling, tissue processing, on-machine sequencing and data analysis, phased estrus and artificial insemination processing are applied, and the estrus time and mating time are adjusted to ensure that tail tissue samples at different developmental stages are collected simultaneously. During sampling, phenotypic data such as fetal body length, body height, tail length, tail width, and tail thickness are measured and recorded.
[0036] 2. Dissociate tissue by enzymatic digestion to prepare high-quality single-cell suspension
[0037] The collected fresh tissue was rinsed with PBS buffer and then chopped up thoroughly. Collagenase IV, DNase and trypsin were used to digest the tissue for 1-2 hours, and red blood cells were lysed with red blood cell lysis buffer to prepare single cell suspension, and multiple indicators such as cell activity, cell concentration, and cell aggregation rate were tested. Single cell transcriptome sequencing requires a cell concentration of 500-2000 / ul and a total cell number of >10 6 , cell viability>90%, and single-cell suspensions that passed quality inspection were used for single-cell transcriptome sequencing.
[0038] 3. Cell capture, library construction and sequencing
[0039] Using 10x Genomics' Chromium Next GEM Single Cell 3′GEM, Library & GelBead Kit v3.1 and Chromium Single Cell A Chip Kit, the Chromium SingleCell Controller instrument was used to capture single cells in the single cell suspension to form an "oil-in-water" structure. After cell lysis, cDNA synthesis, cDNA library quality inspection, sequencing library construction and other steps, sequencing was performed on the machine, and the sequencing data volume was 150GB / 5000 cells.
[0040] 4. Compare the original sequencing data with the reference genome to obtain the original comparison data and the gene expression matrix in each cell
[0041] The raw sequencing data were aligned to the sheep reference genome Oar_rambouillet_v1.0 using Cell Ranger software to obtain data such as the estimated cell number, reference genome mapping rate, and raw barcode-features count matrix for subsequent analysis.
[0042] 5. Cell quality control and gene quality control
[0043] In the process of preparing cell suspension and capturing single cells, it is inevitable to capture dead cells, broken cells and multiple cells (such as double cells) for library construction and sequencing. First, the raw count matrix is quality controlled based on the number of mRNA captured by each cell (number of UMIs) and the proportion of mitochondrial genes; secondly, genes expressed in less than 10 cells are removed; finally, the DoubletFinder software is used to predict double cells and filter to generate a clean count matrix for subsequent analysis.
[0044] 6. Cell-gene expression matrix preprocessing
[0045] Seurat software was used to preprocess the clean count matrix, including: data normalization based on the expression levels of all genes in each cell; identification of the 2000 genes with the highest expression variation and data normalization of these genes; linear dimensionality reduction (PCA) and nonlinear dimensionality reduction (UAMP or tSNE); clustering analysis of all cells to divide cell populations.
[0046] 7. Annotate cells based on known marker genes of different cell types to explore tissue heterogeneity
[0047] Using known marker genes of various cell types, each cell population was annotated by manual annotation method, including: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myoblast marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
[0048] The present invention further provides application of the above method or sheep fat tail single cell transcriptome map in sheep fat tail cell GO function enrichment analysis or gene expression specificity analysis in sheep fat tail cells.
[0049] The present invention also screens highly expressed genes in each cell type and performs GO functional enrichment analysis: Based on the cell annotation results, highly expressed genes in each cell type are screened, with thresholds of adjust p value < 0.05 and log2Fold Change > 0.5. The sheep gene ID is converted into a human homologous gene ID using AnnotationHub and BioMart software, and then the GO functional enrichment analysis is performed using clusterProfiler software and org.Hs.eg.db database, and the pathway with adjust P value < 0.05 is a significantly enriched pathway. The accuracy of the annotation results can be further verified by the enriched GO pathway.
[0050] Based on the screened highly expressed genes, the present invention further evaluated their expression specificity and divided them into four levels: A+, completely specifically expressed genes, which are highly expressed only in a specific cell type; A, highly specifically expressed genes, which are highly expressed only in 10% of cell types; A-, moderately specifically expressed genes, which are highly expressed in 10% to 30% of cell populations; H, other highly expressed genes.
[0051] The present invention divides the expression specificity of genes into four levels: A+, A, A- and H according to the expression level of genes in all cell types. A strategy for evaluating the specificity of gene expression in single-cell maps was designed. Multiple fully specific expression genes (A+) that can be used for annotation of multiple cell types such as progenitor stem cell populations, adipocytes, osteocytes, chondrocytes, myoblasts, and muscle cells were found.
[0052] The beneficial effects of the present invention are at least:
[0053] The present invention conducts single-cell transcriptome sequencing on fat tail tissue of sheep at different embryonic development stages, deeply explores its tissue heterogeneity, constructs a single-cell transcriptome map of fat tail tissue, and designs a method for evaluating gene expression specificity based on the constructed fat tail single-cell transcriptome map, thereby realizing the expression specificity evaluation of highly expressed genes in each cell type and enriching the specific expression genes that can be used to mark different cell types.
[0054] The present invention provides an important theoretical basis for in-depth analysis of the molecular mechanism of tail fat deposition, improving sheep tail shape, improving production efficiency, and improving carcass quality. It also has important reference significance for the application of single-cell transcriptome sequencing technology in the field of fat generation-related research. BRIEF DESCRIPTION OF THE DRAWINGS
[0055] Figure 1 Schematic diagram of the method to construct a single-cell transcriptome profile of sheep fat tail and assess gene expression specificity.
[0056] Figure 2 The figure below shows the distribution of mitochondrial gene proportions (left), RNA molecule quantity distribution (middle) and gene quantity distribution (right) in each sample after cell quality control.
[0057] Figure 3 The prediction results of two cells. From left to right are the predicted two cells, RNA molecule quantity distribution, and gene quantity distribution results.
[0058] Figure 4 The results are divided into cell groups.
[0059] Figure 5 This is a single-cell transcriptome map of lipid tail tissue.
[0060] Figure 6 The expression results of some marker genes in the single-cell transcriptome map, from left to right are adipocyte marker genes, myoblast lineage marker genes, osteocyte marker genes and vascular smooth muscle cell marker genes.
[0061] Figure 7 The expression profiles of highly expressed genes in each cell type and their significantly enriched pathways.
[0062] Figure 8 It is the expression specificity evaluation result of highly expressed genes in each cell type, which is divided into four levels: A+, A, A- and H.
[0063] Fig. 9 Gene expression profiles of A+, A, and A- genes in adipocytes.
[0064] Fig.10 This is the gene expression trend of adipocyte A+ marker genes in different adipogenic differentiation stages. DETAILED DESCRIPTION
[0065] The preferred embodiments of the present invention will be described in detail below in conjunction with examples. It should be understood that the following examples are provided only for the purpose of illustration and are not intended to limit the scope of the present invention. Those skilled in the art may make various modifications and substitutions to the present invention without departing from the purpose and spirit of the present invention.
[0066] The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples are commercially available or prepared according to conventional methods in the art unless otherwise specified.
[0067] The schematic diagram of the method for constructing a single-cell transcriptome profile of sheep fat tail and evaluating gene expression specificity of the present invention is shown in Figure 1 .
[0068] Example 1
[0069] 1. Collection of tail tissue samples of Tan sheep at different developmental stages
[0070] In this example, embryonic tail tissue samples were collected at nine time points, covering all stages before and after tail fat deposition in sheep, including 50, 55, 60, 63, 66, 69, 72, 75 and 80 days of gestation, and high-density time points were used instead of sample biological replicates. In order to reduce the batch effect that may occur in downstream analysis, phased estrus synchronization and artificial insemination technology were used to ensure that all samples were collected at the same time, and the interval between every two batches of estrus treatments was 3 days or 5 days according to the target time point. The specific contents of synchronized estrus and artificial insemination are as follows: vaginal implantation of progesterone sponge plug, which is removed after 11 days; intramuscular injection of 1 ml of cloprostenol injection (0.1 mg / ml) after removal; estrus identification with test rams after 2 days; collection of ram semen, dilution of semen with vitamin B12 injection (3:1) and microscopic examination of sperm motility, artificial insemination of estrus sheep after microscopic examination (sperm motility greater than 50%), a total of 3 inseminations, once every 12 hours to ensure conception rate, all estrus ewes are mated with semen from the same ram to eliminate paternal effect; estrus identification is performed using B-ultrasound after 30 days of mating. When samples are collected, the traits of sheep fetuses at different developmental stages are measured (Table 1), including body length, body height, tail length, tail width and tail thickness.
[0071] Table 1 Body size characteristics of embryos at different developmental stages (unit: mm)
[0072]
[0073]
[0074] 2. Preparation of high-quality single-cell suspension: Rinse the tissue three times with PBS buffer and cut into 1 mm pieces. 3 Size, transfer to a centrifuge tube; add 5-10ml of complex enzyme solution containing collagenase IV, DNA enzyme and trypsin to digest the tissue at 37℃ for 1h. The working concentration of collagenase IV in the complex enzyme solution is 2.5mg / mL, the working concentration of DNA enzyme is 15μg / mL, and the working concentration of trypsin is 0.25%. If the tissue is not completely digested, the time can be appropriately extended; filter the tissue lysate with a 70um filter membrane, centrifuge at 400×g for 5min; resuspend the cell pellet with PBS buffer and add red blood cell lysis buffer at a ratio of 1:3, incubate at room temperature for 10min and then centrifuge; add an appropriate volume of PBS buffer to resuspend the cell pellet, use Count star counter to check the single cell suspension and adjust the cell concentration to 500-2000 cells / μl, the quality inspection results are shown in Table 2. Note: Since the E50 and E55 tail tissues are in the early stage of development, although the cell activity in the prepared single cell suspension is slightly lower than that in other periods, it is still close to 90%, which can be used for single cell transcriptome library sequencing.
[0075] Table 2 Quality inspection results of single cell suspension samples at different periods
[0076]
[0077]
[0078] 3. Cell capture, library construction and sequencing
[0079] The processes of single-cell capture, cDNA synthesis, sequencing library construction, and library purification use 10x Genomics' Chromium Next GEM Single Cell 3′GEM, Library & Gel Bead Kit v3.1 and ChromiumNext GEM Chip G Single Cell Kit. For specific operation details and instruments, please refer to the relevant instruction manual.
[0080] The key process is as follows: this embodiment is designed to capture 5000 cells. According to the cell capture rate, 8000-8500 cells need to be loaded. The loading amount of each sample is calculated according to the cell concentration in Table 2; the single cell in the single cell suspension is captured by the Chromium Single Cell Controller instrument, and an "oil-in-water" structure (i.e., GEM) is formed; the single cell in the GEM structure is lysed, and the 10x barcode sequence and the UMI (unique molecular identifier) sequence are added to the mRNA molecule. At this time, each mRNA molecule of the same cell contains the same 10x barcode sequence and a different UMI sequence; after a series of steps such as reverse transcription, cDNA library quality inspection (the fragment length range is required to be 200-9000bp, and the main peak is between 1000-2000bp), fragmentation and end repair, sequencing library construction, library quality inspection (the library peak shape is required to be between 250bp-1500bp, the main peak is between 400-500bp, and there is no connector contamination), sequencing is performed on the machine, and the sequencing platform is Illumina Novaseq6000, sequencing data volume is 150GB / sample; raw sequencing data quality inspection, data quality is shown in Table 3.
[0081] Table 3. Sample sequencing data quality in each period
[0082]
[0083]
[0084] 4. Compare with the reference genome to obtain the expression matrix
[0085] The original sequencing data were aligned to the sheep reference genome Oar_rambouillet_v1.0 using Cell Ranger software to obtain statistical information such as the predicted cell number, alignment rate, sequencing saturation (results in Table 4) and the cell-gene expression matrix.
[0086] Table 4 Comparison information and cell quality of samples in different periods
[0087]
[0088] 5. Data quality control and preprocessing
[0089] Calculate the outliers between the mitochondrial gene ratio of each cell and the overall mitochondrial gene ratio in each sample, select the minimum mitochondrial gene ratio with adjust p value < 0.05 as the threshold of each sample, delete cells with mitochondrial gene ratio higher than this threshold in each sample, and delete cells with UMI number < 300; then remove genes expressed in less than 10 cells ( Figure 2 ); Finally, the software DoubletFinder was used to predict and filter double cells. Based on the predicted cell numbers, the double cell rates of E50-E80 were 1.6%, 3.9%, 2.3%, 3.1%, 4.6%, 5.4%, 5.4%, 5.4% and 6.1%, respectively ( Figure 3 ). After quality control, a total of 43,557 cells and 20,477 expressed genes were obtained. The samples of each period after quality control were merged to generate a clean count matrix. Seurat software was used for data preprocessing, including: data standardization and normalization, identification of highly variable genes, PCA dimensionality reduction, UMAP dimensionality reduction and cell clustering. Finally, all cells were divided into 37 groups ( Figure 4 ).
[0090] 6. Cell population annotation
[0091] The expression of the following marker genes was used to annotate each cell population, including: TOP2A, a marker gene for progenitor and stem cells (PSC); COL6A6, a marker gene for connective tissue progenitor cells (CTP); PPARG, ADIPOQ, and LPL, a marker gene for preadipocytes and adipocytes; TWIST1, BMP3, and BMP7, a marker gene for precursor osteoblasts and osteocytes; COL8A1 and COL2A1, a marker gene for precursor chondrocytes and chondrocytes; MYOD1 and MYF6, a marker gene for myogenic progenitor cells, muscle satellite cells, myoblasts, and myocytes; ACTA2 and TAGLN, a marker gene for vascular smooth muscle cells (VSMC); PECAM1, a marker gene for endothelial cells; EPCAM, a marker gene for epithelial cells; HBM and HBB, a marker gene for blood cells; PTPRZ1, a marker gene for neural cells; and LTC4S, ITGAM, and CD163, a marker gene for immune cells.
[0092] like Figure 5 As shown, all cells are annotated into 18 major cell types, including a total of 29 cell subtypes. In addition to the above major cell types, the cell subtypes are progenitor and stem cell subtypes: PSC_C1, PSC_C2, PSC_C3, PSC_C4, PSC_C5 and PSC_C6; connective tissue progenitor cell subtypes: CTP_C1, CTP_C2 and CTP_C3; chondrocyte subtypes (Chondrocyte_C1 and Chondrocyte_C2); vascular smooth muscle cells (VSMC_C1 and VSMC_C2); immune cell subtypes (T cells, macrophages and mast cells). The present invention successfully constructed a single-cell transcriptome map of sheep fat tail, and the expression of some marker genes is shown in the figure. Figure 6 shown.
[0093] 7. Screen highly expressed genes in each cell type and perform GO functional enrichment analysis
[0094] Based on the cell annotation results, the Seurat software was used to screen the genes with significant high expression in each cell type, with the thresholds of adjust p value < 0.05 and log2Fold Change > 0.5; the highly expressed gene IDs were converted to human homologous gene IDs using AnnotationHub and BioMart software; and the clusterProfiler software and org.Hs.eg.db database were used for GO functional enrichment analysis. The highly expressed genes in each cell type were enriched in functionally related GO pathways, for example: PSC highly expressed genes were enriched in the mitosis pathway and spindle formation pathway; CTP highly expressed genes were enriched in the extracellular matrix component pathway; preadipocyte and adipocyte highly expressed genes were enriched in the protein-lipid complex pathway and cellular aerobic respiration pathway; muscle cell highly expressed genes were enriched in the muscle fiber composition pathway ( Figure 7 ). The enrichment analysis results further demonstrated the accuracy of cell annotation.
[0095] 8. Specificity evaluation of highly expressed genes and identification of marker genes
[0096] Based on the screened highly expressed genes, the present invention further evaluated their expression specificity ( Figure 8 ), and divided them into four levels: A+, completely specific expression genes, which are highly expressed only in a specific cell type; A, highly specific expression genes, which are highly expressed only in 10% (excluding 10%) of cell types; A-, moderately specific expression genes, which are highly expressed in 10% to 30% of cell populations; H, other highly expressed genes.
[0097] The specific calculation method and formula are as follows:
[0098] Marker A+:
[0099] Marker A:
[0100] Marker A-:
[0101]
[0102] The meaning of each symbol:
[0103] Nc: total number of cell types; MeanExp1: average expression of target gene in target cell types; MeanExp i : The average expression level of the target gene in other cell types; 1(): indicator function, if the condition in the brackets is met, the value is assigned to 1, otherwise it is 0.
[0104] Table 5 shows the number of genes with different levels of specific expression screened in each cell type, as well as the corresponding A+ gene list. Fig. 9 Taking adipocytes as an example, A+ genes such as FABP4, FABP5, ADIRF, LPL, CLDN4, and DBI are only specifically and highly expressed in adipocytes.
[0105] Table 5 Number of genes specifically expressed in each cell type and list of A+ genes
[0106]
[0107]
[0108] 9. Evaluation of marker gene expression in vitro
[0109] In order to further verify the accuracy of the single-cell transcriptome map of sheep fat tail constructed in the present invention and the reliability of the marker genes identified, the present invention further isolated and cultured adipose-derived stem cells in embryonic sheep fat tail tissue in vitro and induced differentiation. Four marker genes (ADRB3, ACACA, FASN and ACSL1) evaluated as A+ in adipocytes were randomly selected, and real-time fluorescence quantitative PCR (RT-qPCR) experiments were performed in cell RNA samples at different differentiation stages. The results are shown in Fig.10 , which showed that the expression levels of these genes increased significantly with the extension of the induction differentiation time, and the highest expression levels were in differentiated mature adipocytes, which fully demonstrated the accuracy of the construction of the single-cell transcriptome map of sheep fat tail and the reliability of the marker genes identified.
[0110] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. A method for constructing a single-cell transcriptome map of sheep fat tail, characterized in that: include: (1) Tail tissue samples of sheep at different embryonic development stages before and after tail fat deposition occurred were collected and prepared into single cell suspensions; (2) capturing a single cell in the single cell suspension, performing cell lysis, cDNA synthesis, cDNA library quality inspection, fragmentation and end repair, constructing a sequencing library, and performing sequencing on a machine to obtain raw test data; (3) comparing the original test data with the reference genome to obtain the original comparison data and the gene expression matrix in each cell; (4) Perform cell quality control based on the amount of mRNA captured in each cell and the proportion of mitochondrial genes; Remove genes expressed in less than 10 cells; perform dual-cell prediction and filtering to obtain quality-controlled samples of each period, merge the quality-controlled samples of each period, and obtain a quality-controlled gene-cell expression matrix for downstream analysis; (5) performing data preprocessing on the gene-cell expression matrix after quality control; (6) Cell annotation was performed based on known marker genes of different cell types to construct a single-cell transcriptome map of sheep fat tail; In step (1), the estrus time and the breeding time are adjusted by synchronizing estrus and artificial insemination in stages, so as to ensure that tail tissue samples of sheep at different embryonic development stages before and after tail fat deposition occur are collected simultaneously; The same male parent is used for mating of each female parent; Synchronized estrus and artificial insemination treatment methods include: The progesterone sponge plug was implanted in the vagina and removed after 11 days; 1 ml of 0.1 mg / ml cloprostenol injection was injected intramuscularly; estrus identification was performed with a test ram 2 days later; semen of the breeding ram was collected, and the semen was diluted with vitamin B12 injection and the sperm motility was examined under a microscope. The volume ratio of the vitamin B12 injection to semen was 3:
1. After the sperm motility was greater than 50% under the microscope, artificial insemination was performed on the estrus ewe, and insemination was performed 3 times in total, once every 12 hours; after 30 days of mating, estrus identification was performed using a B-ultrasound instrument; The different embryonic development stages refer to 50, 55, 60, 63, 66, 69, 72, 75 and 80 days of gestation; In step (1), when preparing a single cell suspension, collagenase IV, DNase and trypsin are used to digest the tissue, and red blood cells are lysed using a red blood cell lysis solution to obtain a single cell suspension; The cell concentration in the single cell suspension is 500-2000 / μl, and the total number of cells is >10 6 The cell viability was >86%.
2. The method according to claim 1, characterized in that In step (2), the quality inspection criteria for the cDNA library are that the fragment length range is 200-9000 bp, and the main peak is between 1000-2000 bp; After constructing the sequencing library, the sequencing library is first quality checked before being sequenced on the machine. The quality inspection standard of the sequencing library is that the peak shape is between 250bp-1500bp, the main peak is between 400-500bp, and there is no adapter contamination; And / or, the amount of sequencing data on the machine is 150GB / 5000 cells.
3. The method according to any one of claims 1 to 2, characterized in that: In step (3), the raw alignment data includes: the predicted number of cells in each period, the average number of reads for each cell, the median number of gene UMIs, sequencing saturation, alignment rate, the total number of genes, and the median number of cell UMIs.
4. The method according to any one of claims 1 to 2, characterized in that: In step (4), the method for cell quality control includes: calculating the outlier situation of the mitochondrial gene ratio of each cell in each sample and the overall mitochondrial gene ratio, screening the minimum mitochondrial gene ratio with adjustp value<0.05 as the threshold of each sample, deleting cells with a mitochondrial gene ratio higher than the threshold in each sample, and deleting cells with a UMI number<300.
5. The method according to claim 3, characterized in that: In step (4), the method for cell quality control includes: calculating the outlier situation of the mitochondrial gene ratio of each cell in each sample and the overall mitochondrial gene ratio, screening the minimum mitochondrial gene ratio with adjust p value < 0.05 as the threshold of each sample, deleting the cells with mitochondrial gene ratio higher than the threshold in each sample, and deleting the cells with UMI number < 300.
6. The method according to any one of claims 1-2 and 5, characterized in that: In step (5), the data preprocessing includes: performing data standardization based on the expression levels of all genes in each cell; performing data normalization on multiple genes with the highest expression level variation; performing linear and nonlinear dimensionality reduction on the data; and performing cluster analysis on all cells to divide the cell populations.
7. The method according to claim 3, characterized in that In step (5), the data preprocessing includes: performing data standardization based on the expression levels of all genes in each cell; performing data normalization on multiple genes with the highest expression level variation; performing linear and nonlinear dimensionality reduction on the data; and performing cluster analysis on all cells to divide the cell populations.
8. The method according to claim 4, characterized in that In step (5), the data preprocessing includes: performing data standardization based on the expression levels of all genes in each cell; performing data normalization on multiple genes with the highest expression level variation; performing linear and nonlinear dimensionality reduction on the data; and performing cluster analysis on all cells to divide the cell populations.
9. The method according to any one of claims 1-2, 5, 7-8, characterized in that: In step (6), the known marker genes include: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myogenic progenitor cell, muscle satellite cell, myoblast and muscle cell marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
10. The method according to claim 3, characterized in that In step (6), the known marker genes include: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myogenic progenitor cell, muscle satellite cell, myoblast and muscle cell marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
11. The method according to claim 4, characterized in that In step (6), the known marker genes include: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myogenic progenitor cell, muscle satellite cell, myoblast and muscle cell marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
12. The method according to claim 6, characterized in that In step (6), the known marker genes include: progenitor cell and stem cell marker gene: TOP2A; connective tissue progenitor cell marker gene: COL6A6; preadipocyte and adipocyte marker genes: PPARG, ADIPOQ and LPL; precursor osteoblast and osteocyte marker genes: TWIST1, BMP3 and BMP7; precursor chondrocyte and chondrocyte marker genes: COL8A1 and COL2A1; myogenic progenitor cell, muscle satellite cell, myoblast and muscle cell marker genes: MYOD1 and MYF6; vascular smooth muscle cell marker genes: ACTA2 and TAGLN; endothelial cell marker gene: PECAM1; epithelial cell marker gene: EPCAM; blood cell marker genes: HBM and HBB; neural cell marker gene: PTPRZ1; immune cell marker genes: LTC4S, ITGAM and CD163.
13. Use of the method according to any one of claims 1 to 12 in GO functional enrichment analysis of sheep fat tail cells.
14. Use of the method according to any one of claims 1 to 12 in specific analysis of gene expression in sheep fat tail cells.
